000 | 01683 a2200469 4500 | ||
---|---|---|---|
005 | 20250515063459.0 | ||
264 | 0 | _c20071015 | |
008 | 200710s 0 0 eng d | ||
022 | _a0022-3042 | ||
024 | 7 |
_a10.1111/j.1471-4159.2007.04504.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRyu, Myung-Jeom | |
245 | 0 | 0 |
_aProteomic analysis of gamma-butyrolactone-treated mouse thalamus reveals dysregulated proteins upon absence seizure. _h[electronic resource] |
260 |
_bJournal of neurochemistry _cAug 2007 |
||
300 |
_a646-56 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a4-Butyrolactone _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium-Binding Proteins _xanalysis |
650 | 0 | 4 |
_aConvulsants _xpharmacology |
650 | 0 | 4 |
_aCytoskeletal Proteins _xanalysis |
650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
650 | 0 | 4 | _aElectrophoresis, Gel, Two-Dimensional |
650 | 0 | 4 |
_aEpilepsy, Absence _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNerve Tissue Proteins _xanalysis |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNeurotransmitter Agents _xbiosynthesis |
650 | 0 | 4 |
_aPresynaptic Terminals _xmetabolism |
650 | 0 | 4 |
_aProteomics _xmethods |
650 | 0 | 4 |
_aThalamus _xdrug effects |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aKim, Daesoo | |
700 | 1 | _aKang, Un-Beom | |
700 | 1 | _aKim, Joon | |
700 | 1 | _aShin, Hee-Sup | |
700 | 1 | _aLee, Cheolju | |
700 | 1 | _aYu, Myeong-Hee | |
773 | 0 |
_tJournal of neurochemistry _gvol. 102 _gno. 3 _gp. 646-56 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1471-4159.2007.04504.x _zAvailable from publisher's website |
999 |
_c16970912 _d16970912 |